Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: S.H. Notes

S.H. Notes

posted on Oct 23, 2007 02:16PM

Just remembered, Question was asked that if they win trial were they prepared to step up the licensing since at the rate they were going (12 a year) it would be 2032 before they reached everyone, and the patents expire in 2015? They answered that they had 30 people working on licensing and they would get most of them. ( I thought why would you leave anything on the table?)

Huntington.  These are my notes and because you don't feel I rose colored them enough for you, that's too bad.

Share
New Message
Please login to post a reply